ATE375154T1 - Pharmazeutische verwendung von cox-2-hemmern in angiogenese-vermittelten augenerkrankungen - Google Patents
Pharmazeutische verwendung von cox-2-hemmern in angiogenese-vermittelten augenerkrankungenInfo
- Publication number
- ATE375154T1 ATE375154T1 AT03731699T AT03731699T ATE375154T1 AT E375154 T1 ATE375154 T1 AT E375154T1 AT 03731699 T AT03731699 T AT 03731699T AT 03731699 T AT03731699 T AT 03731699T AT E375154 T1 ATE375154 T1 AT E375154T1
- Authority
- AT
- Austria
- Prior art keywords
- cox
- angiogenesis
- inhibitors
- pharmaceutical use
- eye diseases
- Prior art date
Links
- 229940111134 coxibs Drugs 0.000 title 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title 1
- 208000030533 eye disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0201520.4A GB0201520D0 (en) | 2002-01-23 | 2002-01-23 | Pharmaceutical uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE375154T1 true ATE375154T1 (de) | 2007-10-15 |
Family
ID=9929598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03731699T ATE375154T1 (de) | 2002-01-23 | 2003-01-22 | Pharmazeutische verwendung von cox-2-hemmern in angiogenese-vermittelten augenerkrankungen |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20050043410A1 (de) |
| EP (1) | EP1503746B1 (de) |
| JP (1) | JP2005515241A (de) |
| CN (1) | CN1283240C (de) |
| AR (1) | AR038198A1 (de) |
| AT (1) | ATE375154T1 (de) |
| BR (1) | BR0307013A (de) |
| CA (1) | CA2468811C (de) |
| CY (1) | CY1106994T1 (de) |
| DE (1) | DE60316792T2 (de) |
| DK (1) | DK1503746T3 (de) |
| ES (1) | ES2291641T3 (de) |
| GB (1) | GB0201520D0 (de) |
| MY (1) | MY145266A (de) |
| PT (1) | PT1503746E (de) |
| TW (1) | TWI280878B (de) |
| WO (1) | WO2003061645A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220422B2 (en) | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| WO2005049014A1 (en) * | 2003-11-18 | 2005-06-02 | Pharmacia Corporation | Cox-2 inhibitors for the treatment or prevention of diabetes-related ocular disorders |
| AU2009291747B2 (en) * | 2008-09-10 | 2016-05-26 | Genentech, Inc. | Methods for inhibiting ocular angiogenesis |
| US9063000B2 (en) * | 2009-05-15 | 2015-06-23 | Glaxosmithkline Llc | Using thermal imaging for control of a manufacturing process |
| WO2019070917A1 (en) * | 2017-10-03 | 2019-04-11 | The Schepens Eye Research Institute, Inc. | COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME |
| CN114652826B (zh) * | 2022-01-24 | 2022-10-14 | 景泽生物医药(合肥)有限公司 | 抗egfr抗体的用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652762A (en) * | 1970-04-14 | 1972-03-28 | Ciba Geigy Corp | Pharmaceutical compositions and methods employing substituted derivatives of 2-anilinophenylacetic acids and esters |
| CO4960662A1 (es) * | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
| US6025353A (en) * | 1997-11-19 | 2000-02-15 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| US6136804A (en) * | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
| CA2362816C (en) * | 1999-12-08 | 2007-02-06 | Pharmacia Corporation | Valdecoxib compositions |
| PE20020351A1 (es) * | 2000-09-11 | 2002-06-14 | Novartis Ag | Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2 |
| AR036312A1 (es) * | 2001-08-31 | 2004-08-25 | Novartis Ag | Composicion farmaceutica |
| WO2003057196A1 (en) * | 2002-01-07 | 2003-07-17 | Pharmacia Corporation | Drug mixture with enhanced dissolution rate |
-
2002
- 2002-01-23 GB GBGB0201520.4A patent/GB0201520D0/en not_active Ceased
-
2003
- 2003-01-20 TW TW092101106A patent/TWI280878B/zh not_active IP Right Cessation
- 2003-01-21 AR ARP030100167A patent/AR038198A1/es unknown
- 2003-01-22 WO PCT/EP2003/000612 patent/WO2003061645A1/en not_active Ceased
- 2003-01-22 BR BR0307013-1A patent/BR0307013A/pt not_active Application Discontinuation
- 2003-01-22 EP EP03731699A patent/EP1503746B1/de not_active Expired - Lifetime
- 2003-01-22 JP JP2003561590A patent/JP2005515241A/ja active Pending
- 2003-01-22 DE DE60316792T patent/DE60316792T2/de not_active Expired - Lifetime
- 2003-01-22 ES ES03731699T patent/ES2291641T3/es not_active Expired - Lifetime
- 2003-01-22 AT AT03731699T patent/ATE375154T1/de active
- 2003-01-22 CN CNB038025833A patent/CN1283240C/zh not_active Expired - Fee Related
- 2003-01-22 PT PT03731699T patent/PT1503746E/pt unknown
- 2003-01-22 MY MYPI20030212A patent/MY145266A/en unknown
- 2003-01-22 US US10/502,180 patent/US20050043410A1/en not_active Abandoned
- 2003-01-22 DK DK03731699T patent/DK1503746T3/da active
- 2003-01-22 CA CA2468811A patent/CA2468811C/en not_active Expired - Fee Related
-
2007
- 2007-11-08 CY CY20071101445T patent/CY1106994T1/el unknown
-
2009
- 2009-06-10 US US12/481,609 patent/US20090247638A1/en not_active Abandoned
-
2012
- 2012-08-24 US US13/593,959 patent/US20120322874A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB0201520D0 (en) | 2002-03-13 |
| TW200302081A (en) | 2003-08-01 |
| WO2003061645A1 (en) | 2003-07-31 |
| DE60316792T2 (de) | 2008-07-24 |
| DK1503746T3 (da) | 2008-02-04 |
| CA2468811C (en) | 2011-08-09 |
| US20090247638A1 (en) | 2009-10-01 |
| DE60316792D1 (de) | 2007-11-22 |
| EP1503746B1 (de) | 2007-10-10 |
| MY145266A (en) | 2012-01-13 |
| EP1503746A1 (de) | 2005-02-09 |
| BR0307013A (pt) | 2004-11-03 |
| US20050043410A1 (en) | 2005-02-24 |
| CY1106994T1 (el) | 2012-09-26 |
| AR038198A1 (es) | 2005-01-05 |
| US20120322874A1 (en) | 2012-12-20 |
| ES2291641T3 (es) | 2008-03-01 |
| TWI280878B (en) | 2007-05-11 |
| CN1620288A (zh) | 2005-05-25 |
| CN1283240C (zh) | 2006-11-08 |
| PT1503746E (pt) | 2008-01-10 |
| JP2005515241A (ja) | 2005-05-26 |
| CA2468811A1 (en) | 2003-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL373333A1 (pl) | Stosowanie przeciwciał skierowanych przeciw TNFalfa i innego leku | |
| DE60201859D1 (de) | Pharmazeutische Verwendung von N-Carbamoylazol-Derivate | |
| DE60315892D1 (de) | Phosphonooxy-chinazolin derivate und ihre pharmazeutische verwendung | |
| MA29067B1 (fr) | Protéines de fusion de RAGE et méthodes d'utilisation | |
| DE60324099D1 (de) | Arzneistoffhaltiger tampon | |
| CY2016035I2 (el) | Θεραπευτικη χρηση αντισωματων anti-cs1 | |
| DE602004021037D1 (de) | Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren | |
| DE60322665D1 (de) | Pharmazeutische darreichungsform mit gesteuerter freigabe eines cholesterylester-transferproteininhibitors | |
| FR2867962B1 (fr) | Plaque d'osteosynthese et spherique | |
| ATE381335T1 (de) | 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung | |
| DE60312780D1 (de) | Wegwerfwindel | |
| ATE418336T1 (de) | Verwendung von i kappa b-kinase inhibitoren in der schmerztherapie | |
| NO20041872L (no) | Esterforbindelser og medisinsk anvendelse derav | |
| DE60324178D1 (de) | THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN | |
| ATE479437T1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
| DE60325967D1 (de) | Stimulierung von hämatopoiese bei ex vivo aktivierten immunzellen | |
| ATE401891T1 (de) | Verwendung von meloxicam-formulierungen in der veterinärmedizin | |
| DE60316792D1 (de) | Pharmazeutische verwendung von cox-2-hemmern in angiogenese-vermittelten augenerkrankungen | |
| NO20035331D0 (no) | Nye heterocyklisk forbindelse og medisinsk anvendelse derav | |
| DE602004022169D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
| ATE494278T1 (de) | Anthranilsäureamide und ihre pharmazeutische verwendung | |
| DE60328787D1 (de) | Pharmazeutische salze von reboxetin | |
| ATE349213T1 (de) | Nasale pharmazeutische zusammensetzung von piribedil | |
| ATE456573T1 (de) | Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen | |
| DE60326437D1 (de) | Therapeutische verwendung von sapogeninen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1503746 Country of ref document: EP |